Free Trial

Ameliora Wealth Management Ltd. Cuts Stock Position in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Ameliora Wealth Management Ltd. reduced its holdings in UnitedHealth Group by 19.4%, ending the second quarter with 4,000 shares valued at approximately $1.248 million.
  • Wells Fargo and Royal Bank of Canada have cut their price targets for UnitedHealth Group, now set at $267 and $286 respectively, while Bank of America raised theirs to $325.
  • UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, resulting in an annualized yield of 2.5% with a payout ratio of 38.30%.
  • MarketBeat previews top five stocks to own in November.

Ameliora Wealth Management Ltd. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,000 shares of the healthcare conglomerate's stock after selling 964 shares during the quarter. Ameliora Wealth Management Ltd.'s holdings in UnitedHealth Group were worth $1,248,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Bayforest Capital Ltd lifted its holdings in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group during the first quarter worth $42,000. Kentucky Trust Co boosted its stake in UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock worth $45,000 after buying an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC lifted its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Wells Fargo & Company reduced their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Weiss Ratings restated a "sell (d+)" rating on shares of UnitedHealth Group in a research note on Saturday, September 27th. Finally, Bank of America boosted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $358.95.

Check Out Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $358.95 on Tuesday. The firm has a market capitalization of $325.09 billion, a P/E ratio of 15.55, a PEG ratio of 2.34 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $309.38 and a 200 day moving average price of $352.34. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines